Prevalence of Histoplasmosis in HIV + Patients with a Rapid Diagnostic Test in West Indies (EDIRAPHIS)
Histoplasmosis in the Guiana Shield and the French West Indies: Evaluating Prevalence in HIV + Patients with a Rapid Diagnostic Test Using an ELISA Capture Method for the Detection of Histoplasma Antigens in Blood and Urine.
Sponsor: ANRS, Emerging Infectious Diseases
Listed as NCT01884779, this observational or N/A phase trial focuses on HIV and remains completed. Sponsored by ANRS, Emerging Infectious Diseases, it has been updated 14 times since 2013, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Oct 2024 — Sep 2025 [monthly]
Completed
Status: Unknown → Completed
-
Sep 2024 — Oct 2024 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
▶ Show 9 earlier versions
-
Oct 2021 — Dec 2021 [monthly]
Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Aug 2019 — Nov 2020 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Aug 2019 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Aug 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ANRS, Emerging Infectious Diseases
For direct contact, visit the study record on ClinicalTrials.gov .